First mRNA Flu Vaccine Receives FDA Approval

Why it matters locally: This national approval means Montanans will likely have access to a new type of flu vaccine for the upcoming season, potentially impacting public health strategies across the state.

---

The Food and Drug Administration (FDA) approved an mRNA-based flu vaccine for use in the upcoming flu season. Moderna, the vaccine's developer, created this new immunization technology. This approval represents the first time an mRNA flu vaccine has received authorization from the FDA. The vaccine will become available to the public in time for the next seasonal influenza period.